| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 02/03/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 02/03/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/28/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/28/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/28/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/28/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/28/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/28/2020 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 01/24/2020 |
8-K
| Other Events |
| 01/23/2020 |
SC 13G
| GOLDMAN SACHS GROUP INC reports a 5.2% stake in ACHILLION PHARMACEUTICALS, INC. |
| 01/17/2020 |
SC 13G/A
| ARP AMERICAS LLC reports a 5.1% stake in Achillion Pharmaceuticals, Inc. |
| 01/16/2020 |
SC 13G
| ARP AMERICAS LLC reports a 5.4% stake in Achillion Pharmaceuticals, Inc. |
| 01/16/2020 |
8-K
| Other Events |
| 12/19/2019 |
8-K
| Quarterly results |
| 12/19/2019 |
GN
| Achillion Shareholders Approve Agreement to be Acquired by Alexion |
| 12/09/2019 |
GN
| Achillion Reports Positive Data from Phase 2 Study of Danicopan (ACH-4471) in Combination with Eculizumab in PNH Patients who Have an Inadequate Response to Eculizumab Monotherapy at the 61st American Society of Hematology Meeting |
|